CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-10 | LEUNG SANDRA EVP, General Counsel | Grant or award · Market Share Units | +24,770 | 24,770 | ||
| 2025-03-10 | LEUNG SANDRA EVP, General Counsel | Option exercise · Performance Shares | −32,096 | 0 | ||
| 2025-03-10 | LEUNG SANDRA EVP, General Counsel | Grant or award · Performance Shares | +37,155 | 37,155 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise | +546 | 2,272 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Other disposition | −38 | 2,234 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Shares withheld for taxes | −219 | $63.11 | $14K | 2,015 |
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise | +835 | 2,850 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Other disposition | −146 | 2,704 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Shares withheld for taxes | −296 | $63.11 | $19K | 2,408 |
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise | +1,050 | 3,458 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Other disposition | −179 | 3,279 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Shares withheld for taxes | −374 | $63.11 | $24K | 2,905 |
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise | +5,015 | 7,920 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Other disposition | −1,850 | 6,070 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Shares withheld for taxes | −1,359 | $63.11 | $86K | 4,711 |
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise · Market Share Units | −546 | 0 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise · Market Share Units | −835 | 838 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise · Market Share Units | −1,050 | 2,102 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Grant or award · Market Share Units | +5,021 | 5,021 | ||
| 2025-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise · Performance Shares | −5,015 | 0 |
Page 21 of 40 · 799 trades